GH and GHBP activity and not IGF-1 and its receptor activity express growth velocity reduction during treatment of central precocious puberty by a superactive GNRH analogue.

Source:http://linkedlifedata.com/resource/pubmed/id/8045738

Download in:

View as

General Info

PMID
8045738